Skip to main content
Solara Active Pharma Sciences Limited (NSE:SOLARA)
India flag India · Delayed Price · Currency is INR
449.55
-9.50 (-2.07%)
At close: Mar 9, 2026

NSE:SOLARA Revenue

Solara Active Pharma Sciences had revenue of 3.49B INR in the quarter ending December 31, 2025, with 16.21% growth. This brings the company's revenue in the last twelve months to 12.55B, down -4.23% year-over-year. In the fiscal year ending March 31, 2025, Solara Active Pharma Sciences had annual revenue of 12.84B, down -0.40%.

Revenue (ttm)
12.55B
Revenue Growth
-4.23%
P/S Ratio
1.73
Revenue / Employee
7.07M
Employees
1,775
Market Cap
21.66B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202512.84B-51.60M-0.40%
Mar 31, 202412.89B-1.55B-10.73%
Mar 31, 202314.44B1.75B13.83%
Mar 31, 202212.68B-3.49B-21.56%
Mar 31, 202116.17B2.95B22.33%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orchid Pharma 8.11B
Indoco Remedies 17.60B
RPG Life Sciences 6.74B
Windlas Biotech 8.68B
Innova Captab 14.97B
Sun Pharma Advanced Research Company 531.36M
Ind-Swift Laboratories 5.94B
Sakar Healthcare 2.31B
Revenue Rankings

Solara Active Pharma Sciences News

More News